VALHALLA, NY, May 6, 2026 – FUJIFILM Americas today announced that Biotechnology Innovation Organization (BIO), the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe, has welcomed Fujifilm’s Crystal Fry-Vanuch as a newly elected member of its Board of Directors for the 2026-2030 term.

Fry-Vanuch serves as Head of Government Affairs for FUJIFILM Americas. Prior to joining Fujifilm in 2023, Fry-Vanuch spent more than 20 years in the biopharmaceutical industry and developed significant expertise in the specialized field of government affairs for global pharmaceutical companies.

“The invitation to join BIO’s board is a tremendous honor,” said Fry-Vanuch. “Fujifilm’s deepening involvement in BIO reflects our commitment to the success of the entire biotech sector. This is an opportunity to work alongside the top leaders in our field during a dynamic time in the industry, and to contribute to policy building and advocacy that is shaping the next era of biotech.”

Fujifilm’s life sciences portfolio of businesses works as “Partners for Life” to offer products, services and comprehensive solutions that support every stage of therapeutic development, from discovery to commercial supply.

“Fujifilm is one of the world’s leading end-to-end solutions providers in the biotechnology space, and our success depends on our worldwide network of partners throughout the biotech ecosystem who rely on our capability and capacity to support the critical touchpoints of their work,” said Toshi Iida, Director and General Manager of Life Science Headquarters, FUJIFILM Corporation. “This gives us a unique perspective and an important voice to bring to the table — not just for Fujifilm, but to reflect the needs and aspirations of our partners.”

Fry-Vanuch and other new members will attend their first meeting as elected members in June, when the board convenes ahead of the BIO International Convention.

Fujifilm will showcase its “Partners for Life” life sciences offerings at booth #3123 during the BIO International Convention, taking place June 22-25 at the San Diego Convention Center. BIO 26 is the largest event in biotechnology, with over 20,000 industry members expected to attend from around the world.

FUJIFILM Americas is the regional headquarters for the Americas. It is comprised of 20 group companies across North and Latin America that are engaged in the research, development, manufacture, sale and service of Fujifilm products and services. The company’s portfolio represents a broad spectrum of industries including medical and life sciences, electronic materials, chemical, graphic arts, information systems, industrial products, broadcast, data storage, and photography. For more information, please visit: https://www.fujifilm.com/us/en/about/region.

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen (29 billion USD at an exchange rate of 140 JPY/USD). For more information, please visit: https://holdings.fujifilm.com/en/.

For further details about our commitment to sustainability and Fujifilm’s Sustainable Value Plan 2030, click here - For further details about our commitment to sustainability and Fujifilm’s Sustainable Value Plan 2030, .